LFWD: Lifeward Company Sales Revenue

ReWalk Robotics Ltd. (LFWD) specializes in developing exoskeletons for patient mobility restoration, holding key positions within the medtech segment. The company's commercial revenue trend confirms product sales dynamics, where the 0.02 indicator expresses the state of the metric. The uniqueness of its home systems allows for flexible pricing power, while patent protection and insurance codes in the US provide a sustainable competitive advantage.

Revenue and Sales Volume: Lifeward (LFWD) for 02/21/2024 - 11/13/2026

Comprehensive metric breakdowns and analytics for Lifeward (LFWD)

- current price and projected stock value:

Share Price Lifeward Ltd.|LFWD - Consensus Target

- market capitalization information:

Market Value ReWalk Robotics|LFWD - Total Company Value

- balance sheet net asset value indicators:

Accounting Value per Share Lifeward|LFWD - Book Capitalization|Market-to-Book Ratio rewalk.com|LFWD - Company Total Assets

- company liabilities and liquidity data:

- company profitability and valuation multiples indicators:

LFWD - Net Income|Expected Net Income ReWalk Robotics Ltd.|LFWD - P/E Multiple|Projected Price to Earnings Ratio rewalk.com|LFWD - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Multiple ReWalk Robotics|LFWD - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Lifeward|LFWD - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months rewalk.com|LFWD - Earnings per share growth in current year|Net earnings per share change forecast for next year ReWalk Robotics Ltd.

- company sales and revenue statistics:

LFWD - Company Revenue|Company Future Sales Volume Lifeward Ltd.|LFWD - P/S Multiple|Market Cap to Future Revenue Ratio ReWalk Robotics

Summary company analysis:LFWD Lifeward Ltd.

ReWalk Robotics Ltd. (LFWD) maintains a dominant position in the rehabilitation exoskeleton sector due to its patent protection and integration into the US insurance system. By analyzing the company's sales dynamics, investors can assess the actual capital inflow from device sales, allowing them to differentiate real market demand from speculative capitalization and confirm the sustainability of the business model amid high barriers to entry for competitors.

Key competitors